Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan 28;15(1):e0227252.
doi: 10.1371/journal.pone.0227252. eCollection 2020.

Multimorbidity gender patterns in hospitalized elderly patients

Affiliations

Multimorbidity gender patterns in hospitalized elderly patients

Pere Almagro et al. PLoS One. .

Abstract

Patients with multimorbidity and complex health care needs are usually vulnerable elders with several concomitant advanced chronic diseases. Our research aim was to evaluate differences in patterns of multimorbidity by gender in this population and their possible prognostic implications, measured as in-hospital mortality, 1-month readmissions, and 1-year mortality. We focused on a cohort of elderly patients with well-established multimorbidity criteria admitted to a specific unit for chronic complex-care patients. Multimorbidity criteria, the Charlson, PROFUND and Barthel indexes, and the Pfeiffer test were collected prospectively during their stays. A total of 843 patients (49.2% men) were included, with a median age of 84 [interquartile range (IQR) 79-89] years. The women were older, with greater functional dependence [Barthel index: 40 (IQR:10-65) vs. 60 (IQR: 25-90)], showed more cognitive deterioration [Pfeiffer test: 5 (IQR:1-9) vs. 1 (0-6)], and had worse scores on the PROFUND index [15 (IQR:9-18) vs. 11.5 (IQR: 6-15)], all p <0.0001, while men had greater comorbidity measured with the Charlson index [5 (IQR: 3-7) vs. 4 (IQR: 3-6); p = 0.002]. In the multimorbidity criteria scale, heart failure, autoimmune diseases, dementia, and osteoarticular diseases were more frequent in women, while ischemic heart disease, chronic respiratory diseases, and neoplasms predominated in men. In the analysis of grouped patterns, neurological and osteoarticular diseases were more frequent in females, while respiratory and cancer predominated in males. We did not find gender differences for in-hospital mortality, 1-month readmissions, or 1-year mortality. In the multivariate analysis age, the Charlson, Barthel and PROFUND indexes, along with previous admissions, were independent predictors of 1-year mortality, while gender was non-significant. The Charlson and PROFUND indexes predicted mortality during follow-up more accurately in men than in women (AUC 0.70 vs. 0.57 and 0.74 vs. 0.62, respectively), with both p<0.001. In conclusion, our study shows differing patterns of multimorbidity by gender, with greater functional impairment in women and more comorbidity in men, although without differences in the prognosis. Moreover, some of these prognostic indicators had differing accuracy for the genders in predicting mortality.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Flowchart of participants.
Fig 2
Fig 2. The diameter of the spheres represents the prevalence in pattern percentage, while union lines express the frequency of the relationship.
Violet lines >60%, Blue lines 51–60%, Red lines 41–50%, Green lines 31–40%%, Orange lines 21–30, Brown lines 11–20%, Black lines <11%. * The association between patterns is statistically significantly higher in men than in women. & The association between patterns is statistically significantly higher in women than in men.
Fig 3
Fig 3. Main cause and gender differences in 30-day readmissions.
Fig 4
Fig 4. Kaplan-Meier survival curves and gender.
Fig 5
Fig 5. Dynamic cumulative ROC curves and1-year mortality for PROFUND, Charlson index, and Barthel scale.
Black = male. Gray = female.

References

    1. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1859–1922. 10.1016/S0140-6736(18)32335-3 . - DOI - PMC - PubMed
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross-sectional study. Lancet. 2012;380(9836):37–43. 10.1016/S0140-6736(12)60240-2 - DOI - PubMed
    1. Clerencia-Sierra M, Calderón-Larrañaga A, Martínez-Velilla N, Vergara-Mitxeltorena I, Aldaz-Herce P, Poblador-Plou B, et al. Multimorbidity patterns in hospitalized older patients: associations among chronic diseases and geriatric syndromes. PLoS One. 2015;10(7):e0132909 10.1371/journal.pone.0132909 0132909. - DOI - PMC - PubMed
    1. Yarnall AJ, Sayer AA, Clegg A, Rockwood K, Parker S, Hindle J V. New horizons in multimorbidity in older adults. Age Ageing. 2017;46:882–888. 10.1093/ageing/afx150 - DOI - PMC - PubMed
    1. Buja A, Claus M, Perin L, Rivera M, Corti MC, Avossa F,et al. Multimorbidity patterns in high-need, high-cost elderly patients. PLoS ONE.2018;13: e0208875 10.1371/journal.pone.0208875 - DOI - PMC - PubMed